Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors

Bioorganic & Medicinal Chemistry Letters
2011.0

Abstract

We report here the synthesis and SAR of a new series of thieno[3,2-d]pyrimidines as potent Tpl2 kinase inhibitors. The proposed binding mode suggests the potential flipped binding mode depending on the substitution. Biacore studies show evidence of binding of these molecules to the protein kinase. The kinome inhibition profile of these molecules suggests good selectivity.

Knowledge Graph

Similar Paper

Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Design of novel N-(2,4-dioxo-1,2,3,4-tetrahydro-thieno[3,2-d]pyrimidin-7-yl)-guanidines as thymidine phosphorylase inhibitors, and flexible docking to a homology model
Bioorganic & Medicinal Chemistry Letters 2003.0
Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases
Bioorganic & Medicinal Chemistry Letters 2008.0
2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode
Bioorganic & Medicinal Chemistry Letters 2010.0
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors
European Journal of Medicinal Chemistry 2018.0
Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: Synthesis and SAR studies
Bioorganic & Medicinal Chemistry Letters 2006.0
Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors
Journal of Medicinal Chemistry 2005.0
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
Design, synthesis and structure-activity relationship study of piperazinone-containing thieno[3,2-d]pyrimidine derivatives as new PI3Kδ inhibitors
Bioorganic & Medicinal Chemistry Letters 2020.0
Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors
Bioorganic & Medicinal Chemistry Letters 2007.0